leading brands of glp-1 agonists in biopharma Comparing Ozempic, Wegovy and Other Drugs Glucagon-like Peptide-1 (GLP-1) Agonists Market

10.1038/ajg.2010.363 56

GLP-1 Analogue Improves Hepatic Lipid Accumulation by Inducing Autophagy via AMPK/mTOR Pathway

Ladenheim, E

Lancet (London, England)

There have been reports of gallbladder disease, including cholelithiasis and cholecystitis, possibly related to rapid weight loss

It affects the GLP one receptor but also the GIP receptor, which are both involved in hunger and satiety and motility. Dan Azagury, MD, FACS, the chief bariatric surgeon and medical director of Stanford University School of Medicines Lifestyle and Weight Management Clinic in California, who also was not involved in the Eli Lilly study, told Healthline that he was not surprised at the studys results